Logo
V

Vitestro

113 employees

Vitestro will be the first to bring autonomous blood drawing technology to European hospitals. Blood drawing, performed billions of times per year worldwide, is key to clinical diagnosis. Given a growing population and shortages of healthcare personnel, there is a clear need for a future-proof system to keep up with demand for diagnostics.

Investor insights

Funding rounds participated in

$21M sweet spot round size

Investor type

Privately Held

Basic info

Industry

Medical Equipment Manufacturing

Sectors

Medical Equipment Manufacturing

Date founded

2017

Funding rounds raised

Total raised

$21M

from 3 investors over 1 rounds

V

Vitestro raised $21M on May 30, 2024

Investors: NYBC Ventures, Sonder Capital and + 2 Other investors

FAQ